Literature DB >> 33761113

Mechanistic diversity involved in the desensitization of G protein-coupled receptors.

Ningning Sun1, Kyeong-Man Kim2.   

Abstract

The desensitization of G protein-coupled receptors (GPCRs), which involves rapid loss of responsiveness due to repeated or chronic exposure to agonists, can occur through various mechanisms at different levels of signaling pathways. In this review, the mechanisms of GPCR desensitization are classified according to their occurrence at the receptor level and downstream to the receptor. The desensitization at the receptor level occurs in a phosphorylation-dependent manner, wherein the activated receptors are phosphorylated by GPCR kinases (GRKs), thereby increasing their affinities for arrestins. Arrestins bind to receptors through the cavity on the cytoplasmic region of heptahelical domains and interfere with the binding and activation of G-protein. Diverse mechanisms are involved in the desensitization that occurs downstream of the receptor. Some of these include the sequestration of G proteins, such as Gq and Gi/o by GRK2/3 and deubiquitinated arrestins, respectively. Mechanistically, GRK2/3 attenuates GPCR signaling by sequestering the Gα subunits of the Gq family and Gβγ via regulators of G protein signaling and pleckstrin homology domains, respectively. Moreover, studies on Gi/o-coupled D2-like receptors have reported that arrestins are deubiquitinated under desensitization condition and form a stable complex with Gβγ, thereby preventing them from coupling with Gα and the receptor, eventually leading to receptor signaling inhibition. Notably, the desensitization mechanism that involves arrestin deubiquitination is interesting; however, this is a new mechanism and needs to be explored further.

Entities:  

Keywords:  Arrestin; Desensitization; Deubiquitination; G protein-coupled receptors; Gβγ; Mdm2

Year:  2021        PMID: 33761113     DOI: 10.1007/s12272-021-01320-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  102 in total

1.  Light activation of one rhodopsin molecule causes the phosphorylation of hundreds of others. A reaction observed in electropermeabilized frog rod outer segments exposed to dim illumination.

Authors:  B M Binder; M S Biernbaum; M D Bownds
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

2.  Synthetic peptides of the hamster beta 2-adrenoceptor as substrates and inhibitors of the beta-adrenoceptor kinase.

Authors:  J L Benovic; J Onorato; M J Lohse; H G Dohlman; C Staniszewski; M G Caron; R J Lefkowitz
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

3.  Phosphorylation of non-bleached rhodopsin in intact retinas and living frogs.

Authors:  B M Binder; T M O'Connor; M D Bownds; V Y Arshavsky
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

4.  Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein).

Authors:  J L Benovic; H Kühn; I Weyand; J Codina; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Regulation of adrenergic receptor function by phosphorylation. II. Effects of agonist occupancy on phosphorylation of alpha 1- and beta 2-adrenergic receptors by protein kinase C and the cyclic AMP-dependent protein kinase.

Authors:  M Bouvier; L M Leeb-Lundberg; J L Benovic; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

6.  Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein.

Authors:  J L Benovic; L J Pike; R A Cerione; C Staniszewski; T Yoshimasa; J Codina; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1985-06-10       Impact factor: 5.157

7.  Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists.

Authors:  Nicolas Audet; Iness Charfi; Ouissame Mnie-Filali; Mohammad Amraei; Anne-Julie Chabot-Doré; Magali Millecamps; Laura S Stone; Graciela Pineyro
Journal:  J Neurosci       Date:  2012-04-04       Impact factor: 6.167

8.  Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.

Authors:  Antony D Abraham; Selena S Schattauer; Kathryn L Reichard; Joshua H Cohen; Harrison M Fontaine; Allisa J Song; Salina D Johnson; Benjamin B Land; Charles Chavkin
Journal:  J Neurosci       Date:  2018-08-03       Impact factor: 6.167

9.  Mechanistic studies on rhodopsin kinase. Light-dependent phosphorylation of C-terminal peptides of rhodopsin.

Authors:  N G Brown; C Fowles; R Sharma; M Akhtar
Journal:  Eur J Biochem       Date:  1992-09-15

10.  Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family.

Authors:  H Attramadal; J L Arriza; C Aoki; T M Dawson; J Codina; M M Kwatra; S H Snyder; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

View more
  3 in total

Review 1.  Aldosterone breakthrough from a pharmacological perspective.

Authors:  Masaki Mogi
Journal:  Hypertens Res       Date:  2022-04-14       Impact factor: 5.528

2.  Addition of a carboxy-terminal tail to the normally tailless gonadotropin-releasing hormone receptor impairs fertility in female mice.

Authors:  Chirine Toufaily; Jérôme Fortin; Carlos Ai Alonso; Evelyne Lapointe; Xiang Zhou; Yorgui Santiago-Andres; Yeu-Farn Lin; Yiming Cui; Ying Wang; Dominic Devost; Ferdinand Roelfsema; Frederik Steyn; Aylin C Hanyaloglu; Terence E Hébert; Tatiana Fiordelisio; Derek Boerboom; Daniel J Bernard
Journal:  Elife       Date:  2021-12-23       Impact factor: 8.140

3.  Arrestin Facilitates Rhodopsin Dephosphorylation in Vivo.

Authors:  Chia-Ling Hsieh; Yun Yao; Vsevolod V Gurevich; Jeannie Chen
Journal:  J Neurosci       Date:  2022-03-24       Impact factor: 6.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.